Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection

Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Stylianou, E, Betts, G, Dicks, M, Griffiths, K, Poyntz, H, Mcshane, H
Μορφή:	Conference item
Έκδοση:	2011

Παρόμοια τεκμήρια

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection
ανά: Betts, G, κ.ά.
Έκδοση: (2012)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
ανά: Griffiths, K, κ.ά.
Έκδοση: (2013)

Optimising immunogenicity with viral vectors: mixing MVA and HAdV-5 expressing the mycobacterial antigen Ag85A in a single injection.
ανά: Gareth Betts, κ.ά.
Έκδοση: (2012-01-01)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
ανά: Griffiths, K, κ.ά.
Έκδοση: (2011)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
ανά: Stylianou, E, κ.ά.
Έκδοση: (2015)

Evaluation of immunological mechanisms induced by Mycobacterium avium exposure and the effect upon pre-existing BCG immunity
ανά: Poyntz, H, κ.ά.
Έκδοση: (2011)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
ανά: Poyntz, H, κ.ά.
Έκδοση: (2014)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
ανά: Marsay, L, κ.ά.
Έκδοση: (2013)

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis
ανά: Poyntz, H, κ.ά.
Έκδοση: (2014)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
ανά: Marsay, L, κ.ά.
Έκδοση: (2013)

Novel mRNA vaccines induce potent immunogenicity and afford protection against tuberculosis
ανά: Christopher J. De Voss, κ.ά.
Έκδοση: (2025-02-01)

Viral vector delivery of Env trimer immunogens
ανά: Parks CL, κ.ά.
Έκδοση: (2012-09-01)

Uncovering the mechanisms of adenovirus vector immunogenicity
ανά: Dicks, M, κ.ά.
Έκδοση: (2013)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery.
ανά: Meyer, J, κ.ά.
Έκδοση: (2013)

Viral vectors as vaccine platforms: from immunogenicity to impact
ανά: Ewer (nee Russell), K, κ.ά.
Έκδοση: (2016)

Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
ανά: Meyer, J, κ.ά.
Έκδοση: (2013)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
ανά: Biswas, S, κ.ά.
Έκδοση: (2011)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
ανά: Poyntz, HC
Έκδοση: (2012)

Enhanced immunogenicity of CD4(+) t-cell responses and protective efficacy of a DNA-modified vaccinia virus Ankara prime-boost vaccination regimen for murine tuberculosis.
ανά: Mcshane, H, κ.ά.
Έκδοση: (2001)

Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: a phase I clinical trial.
ανά: Rowland, R, κ.ά.
Έκδοση: (2013)

Transgene optimization, immunogenicity and in vitro efficacy of viral vectored vaccines expressing two alleles of Plasmodium falciparum AMA1.
ανά: Sumi Biswas, κ.ά.
Έκδοση: (2011-01-01)

Improved systems for generating and evaluating adenovirus vaccine vectors reveal differences in immunogenicity between vectors of different adenoviral species
ανά: Dicks, M, κ.ά.
Έκδοση: (2011)

Immunogenicity and Protective Efficacy of a Recombinant Pichinde Viral-Vectored Vaccine Expressing Influenza Virus Hemagglutinin Antigen in Pigs
ανά: Sushmita Kumari, κ.ά.
Έκδοση: (2022-08-01)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-riming and boosting with adenovirus or protein based vaccines
ανά: Dean, G, κ.ά.
Έκδοση: (2014)

Assessment of immunogenicity and neutralisation efficacy of viral-vectored vaccines against Chikungunya virus
ανά: López-Camacho, C, κ.ά.
Έκδοση: (2019)

Fighting Fire with Fire: Immunogenicity of Viral Vectored Vaccines against COVID-19
ανά: Aiquan Chang, κ.ά.
Έκδοση: (2022-02-01)

Assessment of Immunogenicity and Neutralisation Efficacy of Viral-Vectored Vaccines Against Chikungunya Virus
ανά: César López-Camacho, κ.ά.
Έκδοση: (2019-04-01)

Protection by Persuasion: International Cooperation in the Refugee Regime
ανά: Betts, A
Έκδοση: (2010)

Comparison of the immunogenicity and protection against bovine tuberculosis following immunization by BCG-priming and boosting with adenovirus or protein based vaccines.
ανά: Dean, G, κ.ά.
Έκδοση: (2014)

A novel chimpanzee adenovirus vector with low human seroprevalence: improved systems for vector derivation and comparative immunogenicity.
ανά: Dicks, M, κ.ά.
Έκδοση: (2012)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
ανά: Vordermeier, H, κ.ά.
Έκδοση: (2009)

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals.
ανά: Sander, C, κ.ά.
Έκδοση: (2009)

Evaluation of the safety and immunogenicity of a candidate tuberculosis vaccine, MVA85A, delivered by aerosol to the lungs of macaques.
ανά: White, A, κ.ά.
Έκδοση: (2013)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
ανά: Vordermeier, H, κ.ά.
Έκδοση: (2011)

Immunogenicity and protective efficacy of inactivated coxsackievirus B4 viral particles
ανά: Tingfeng Wang, κ.ά.
Έκδοση: (2024-12-01)

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guerin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara.
ανά: Goonetilleke, N, κ.ά.
Έκδοση: (2003)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
ανά: Stylianou, E, κ.ά.
Έκδοση: (2019)

The Use of Viral Vectors for Gene Therapy and Vaccination in Tuberculosis
ανά: Dulce Mata-Espinosa, κ.ά.
Έκδοση: (2023-10-01)

Safety and immunogenicity of the candidate tuberculosis vaccine MVA85A in West Africa.
ανά: Brookes, R, κ.ά.
Έκδοση: (2008)

Evaluation of Duration of Immunogenicity and Protective Efficacy of Improved Influenza Viral Vector–Based Brucella abortus Vaccine Against Brucella melitensis Infection in Sheep and Goats
ανά: Aigerim Mailybayeva, κ.ά.
Έκδοση: (2020-02-01)